Resolution of mandibular fibrous dysplasia following imatinib therapy in Noonan syndrome

Pediatr Blood Cancer. 2023 Jun;70(6):e30282. doi: 10.1002/pbc.30282. Epub 2023 Mar 11.

Authors

Joshua W Goldman¹, Sean Edwards², Rajen Mody¹, Rama Jasty-Rao¹

Affiliations

¹ Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA.
² Department of Oral and Maxillofacial Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.

PMID: 36905190
DOI: 10.1002/pbc.30282

No abstract available

Publication types

Letter

MeSH terms

Humans
Imatinib Mesylate
Mandible
Mandibular Diseases*
Noonan Syndrome*

Substances

Imatinib Mesylate